Valuation: Navamedic ASA

Market Cap 388M 40.55M 35.61M 33.12M 30.39M 57.11M 3.9B 57.99M 393M 154M 1.92B 152M 149M 6.64B P/E 2026 *
-295x
P/E 2027 * 36.4x
Enterprise Value 508M 53.07M 46.61M 43.35M 39.78M 74.74M 5.11B 75.9M 515M 201M 2.51B 199M 195M 8.69B EV / Sales 2026 *
0.87x
EV / Sales 2027 * 0.74x
Free-Float
30.82%
Yield 2026 *
-
Yield 2027 * -
1 day+1.23%
1 week+2.18%
Current month+0.31%
1 month+1.23%
3 months-17.17%
6 months-25.11%
Current year-31.09%
1 week 15.7
Extreme 15.7
16.95
1 month 15.7
Extreme 15.7
17.45
Current year 15.7
Extreme 15.7
24.5
1 year 15.7
Extreme 15.7
27.9
3 years 15.7
Extreme 15.7
43.9
5 years 15.7
Extreme 15.7
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 60 31/12/2018
Director of Finance/CFO - 31/12/2025
Compliance Officer - -
Director TitleAgeSince
Chairman 66 -
Director/Board Member 60 31/05/2024
Director/Board Member - 31/05/2023
Date Insider Type Main position Quantity % Market Cap.
19/12/24 Buy

Chief Operating Officer

10,267 0.0581%
09/09/24 Fiscal year

Chief Operating Officer

75,000 0.4302%
09/09/24 Fiscal year

Executive/Senior Manager

75,000 0.4302%
Change 5-day change 1-year change 3-year change Capi.($)
+1.23%+2.18%-32.23%-54.57% 40.38M
+1.29%+2.00%+49.32%+161.84% 1,057B
+1.42%+4.03%+55.25%+53.87% 624B
+0.79%+1.85%+35.82%+81.02% 454B
+1.60%+6.25%+33.95%+29.84% 341B
-0.60%+1.52%+35.68%+39.76% 297B
-0.14%+0.60%+16.17%+17.53% 262B
+0.09%-2.82%-28.29%-41.71% 215B
+1.40%+2.88%+22.13%+60.06% 201B
-0.59%-3.15%+14.89%+67.46% 162B
Average +0.70%+0.79%+20.27%+41.51% 361.4B
Weighted average by Cap. +0.90%+1.57%+35.99%+78.07%

Financials

2026 *2027 *
Net sales 588M 61.36M 53.89M 50.12M 45.99M 86.41M 5.91B 87.74M 595M 233M 2.9B 230M 225M 10.04B 643M 67.16M 58.99M 54.86M 50.34M 94.58M 6.47B 96.04M 651M 254M 3.18B 252M 247M 10.99B
Net income -1.5M -156K -137K -127K -117K -220K -15.03M -223K -1.51M -591K -7.39M -586K -573K -25.54M 10.7M 1.12M 981K 912K 837K 1.57M 108M 1.6M 10.83M 4.23M 52.87M 4.19M 4.1M 183M
Net Debt 120M 12.52M 11M 10.23M 9.39M 17.64M 1.21B 17.91M 121M 47.46M 593M 47.02M 46.01M 2.05B 87.4M 9.12M 8.01M 7.45M 6.84M 12.85M 878M 13.04M 88.48M 34.57M 432M 34.25M 33.51M 1.49B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
24/07/26 NOK 16.40 +1.23% 9,916
23/07/26 NOK 16.20 +0.31% 1,900
22/07/26 NOK 16.15 +2.87% 12,620
21/07/26 NOK 15.70 -2.18% 5,281
20/07/26 NOK 16.05 0.00% 8,428
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.20NOK
Average target price
23.50NOK
Spread / Average Target
+45.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock